Tolerability, Safety, and Efficacy Study of INGAP Peptide to Treat Type 1 Diabetes Mellitus in Adults

This study has been terminated.
(Preserve clinical supplies)
Sponsor:
Information provided by (Responsible Party):
Exsulin Corporation
ClinicalTrials.gov Identifier:
NCT00995540
First received: October 13, 2009
Last updated: February 11, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2011
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)